Pfizer says COVID-19 pill cut hospital, death risk by 90%

WASHINGTON (AP) — Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in high-risk adults, as the drugmaker joined the race for an easy-to-use medication to treat the coronavirus.
Read more: https://apnews.com/article/coronavirus-pandemic-science-business-health-medication-eeea3c6a5f6428479e35bc1bcd7aec52?source=Snapzu